SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: October 16, 2008
(Date of earliest event reported)
VASOMEDICAL, INC.
-----------------
(Exact name of registrant as specified in its charter)
Delaware 0-18105 11-2871434
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
180 Linden Avenue, Westbury, New York 11590
------------------------------------- -----
(Address of principal executive offices) (Zip Code)
Registrant's telephone number including area code (516) 997-4600
--------------
Not applicable
--------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
Effective October 16, 2008, Jun Ma, PhD, a director of the Company since
June 2007, was appointed by the Board of Directors as its Chief Executive
Officer and President, to serve at the pleasure of the Board. Mr. Ma's
compensation will be at the annual rate of $100,000. Mr. Ma holds a BS degree in
precision machinery and instrumentation from China University of Science and
Technology, an MS degree in biomedical instrumentation from Shanghai University,
and a PhD degree in mechanical engineering from Columbia University in the city
of New York. He has been an associate professor in engineering at New York
Institute of Technology since 1997 and an assistant professor from 1993 to 1997.
Mr. Ma currently provides consulting services to several companies, including
Kerns Manufacturing Corp. and Living Data Technology Corp., both of whom are
shareholders of our Company. Mr. Ma replaces John C. K. Hui, PhD, who has been
appointed Vice Chairman of the Board of Directors and Chief Technology Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
VASOMEDICAL, INC.
By: /s/ Jun Ma
-------------------------------------
President and Chief Executive Officer
Dated: October 16, 2008